D-1120-2019 Class II Terminated
FDA drug recall D-1120-2019 was initiated by Glenmark Pharmaceuticals Inc., USA on Mar 25, 2019 and is designated Class II. Reason for recall: Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg. The recall status is terminated (terminated Sep 14, 2020). Affected quantity: 2076 500-count Bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Apr 17, 2019
- Initiation Date
- Mar 25, 2019
- Termination Date
- Sep 14, 2020
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 2076 500-count Bottles
Product description
Pravastatin Sodium Tablets USP, 20 mg, 500-count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd. Plot No. 2, Phase-2, Pharma zone SEZ, Pithampur, Dist-Dhar, Madhya Pradesh 454 775, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430. NDC 68462-196-05
Reason for recall
Presence Of Foreign Tablet: in a bottle of Pravastatin Sodium Tablets 20 mg.
Distribution pattern
Nationwide in the USA
Code information
Lot 17181491 Exp. Aug. 2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1120-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026